204 related articles for article (PubMed ID: 36291610)
21. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
[TBL] [Abstract][Full Text] [Related]
22. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J
Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865
[TBL] [Abstract][Full Text] [Related]
23. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies.
Li W; Zhang H; Assaraf YG; Zhao K; Xu X; Xie J; Yang DH; Chen ZS
Drug Resist Updat; 2016 Jul; 27():14-29. PubMed ID: 27449595
[TBL] [Abstract][Full Text] [Related]
24. Low dose HSP90 inhibition with AUY922 blunts rapid evolution of metastatic and drug resistant phenotypes induced by TGF-β and paclitaxel in A549 cells.
Bacon NA; Larre I; Lawag AA; Merritt C; Smith M; Rosolen M; Sollars VE
Biomed Pharmacother; 2020 Sep; 129():110434. PubMed ID: 32768937
[TBL] [Abstract][Full Text] [Related]
25. ABC Transporter-Mediated Multidrug-Resistant Cancer.
Amawi H; Sim HM; Tiwari AK; Ambudkar SV; Shukla S
Adv Exp Med Biol; 2019; 1141():549-580. PubMed ID: 31571174
[TBL] [Abstract][Full Text] [Related]
26. Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells.
Chen Y; Scully M; Petralia G; Kakkar A
Cancer Biol Ther; 2014 Jan; 15(1):135-45. PubMed ID: 24253450
[TBL] [Abstract][Full Text] [Related]
27. Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer.
Kim YH; Ishii G; Goto K; Ota S; Kubota K; Murata Y; Mishima M; Saijo N; Nishiwaki Y; Ochiai A
Lung Cancer; 2009 Jul; 65(1):105-11. PubMed ID: 19036469
[TBL] [Abstract][Full Text] [Related]
28. Quantitative proteomics in lung cancer.
Cheung CHY; Juan HF
J Biomed Sci; 2017 Jun; 24(1):37. PubMed ID: 28615068
[TBL] [Abstract][Full Text] [Related]
29. Resistant mechanisms of anthracyclines--pirarubicin might partly break through the P-glycoprotein-mediated drug-resistance of human breast cancer tissues.
Kubota T; Furukawa T; Tanino H; Suto A; Otan Y; Watanabe M; Ikeda T; Kitajima M
Breast Cancer; 2001; 8(4):333-8. PubMed ID: 11791127
[TBL] [Abstract][Full Text] [Related]
30. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
[TBL] [Abstract][Full Text] [Related]
31. An investigation of heat shock protein 27 and P-glycoprotein mediated multi-drug resistance in breast cancer using liquid chromatography-tandem mass spectrometry-based targeted proteomics.
Xu F; Yang T; Fang D; Xu Q; Chen Y
J Proteomics; 2014 Aug; 108():188-97. PubMed ID: 24882106
[TBL] [Abstract][Full Text] [Related]
32. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
Chiang CD; Song EJ; Yang VC; Chao CC
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
[TBL] [Abstract][Full Text] [Related]
33. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
34. Drug resistance-associated changes in sphingolipids and ABC transporters occur in different regions of membrane domains.
Hinrichs JW; Klappe K; van Riezen M; Kok JW
J Lipid Res; 2005 Nov; 46(11):2367-76. PubMed ID: 16150833
[TBL] [Abstract][Full Text] [Related]
35. Quantitative proteomics analysis identifies mitochondria as therapeutic targets of multidrug-resistance in ovarian cancer.
Chen X; Wei S; Ma Y; Lu J; Niu G; Xue Y; Chen X; Yang F
Theranostics; 2014; 4(12):1164-75. PubMed ID: 25285166
[TBL] [Abstract][Full Text] [Related]
36. Role of RLIP76 in doxorubicin resistance in lung cancer.
Vatsyayan R; Chaudhary P; Lelsani PC; Singhal P; Awasthi YC; Awasthi S; Singhal SS
Int J Oncol; 2009 Jun; 34(6):1505-11. PubMed ID: 19424567
[TBL] [Abstract][Full Text] [Related]
37. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH
PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247
[TBL] [Abstract][Full Text] [Related]
38. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
[TBL] [Abstract][Full Text] [Related]
39. Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance.
Versantvoort CH; Withoff S; Broxterman HJ; Kuiper CM; Scheper RJ; Mulder NH; de Vries EG
Int J Cancer; 1995 May; 61(3):375-80. PubMed ID: 7729950
[TBL] [Abstract][Full Text] [Related]
40. A systematic quantitative proteomic examination of multidrug resistance in Acinetobacter baumannii.
Chopra S; Ramkissoon K; Anderson DC
J Proteomics; 2013 Jun; 84():17-39. PubMed ID: 23542354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]